0001209191-19-061009.txt : 20191217 0001209191-19-061009.hdr.sgml : 20191217 20191217185714 ACCESSION NUMBER: 0001209191-19-061009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191216 FILED AS OF DATE: 20191217 DATE AS OF CHANGE: 20191217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Novack David F CENTRAL INDEX KEY: 0001573072 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34207 FILM NUMBER: 191290950 MAIL ADDRESS: STREET 1: 39 YORKSHIRE DR CITY: OAKLAND STATE: CA ZIP: 94618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001029142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330728374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2929 SEVENTH STREET STREET 2: SUITE 100 CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 5108485100 MAIL ADDRESS: STREET 1: 2929 SEVENTH STREET STREET 2: SUITE 100 CITY: BERKELEY STATE: CA ZIP: 94710 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-16 0 0001029142 DYNAVAX TECHNOLOGIES CORP DVAX 0001573072 Novack David F C/O DYNAVAX TECHNOLOGIES 2100 POWELL STREET, SUITE 900 EMERYVILLE CA 94608 0 1 0 0 President & COO Stock Option (Right to Buy) 6.80 2019-12-16 4 A 0 200000 0.00 A 2026-12-15 Common Stock 200000 200000 D This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date, and one thirty-sixth (1/36) of the shares subject to the option vesting on the last day of each month thereafter. /s/ David Novack 2019-12-17